Johnson Chemical Pharmaceutical Works (4747) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 強生*

Johnson Chemical Pharmaceutical Works (4747) reported revenue of NT$50.1 million for Oct 2026, -2.7% year on year and +2.2% from the previous month. Revenue for Jan–Oct 2026 was NT$492.4 million (+4.6% year on year).

In Oct 2026, it ranked No. 99 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$49.9 million24/10Nov 2024 NT$50.8 millionDec 2024 NT$47.2 millionJan 2025 NT$59.1 millionFeb 2025 NT$40.5 million25/02Mar 2025 NT$47.2 millionApr 2025 NT$46.5 millionMay 2025 NT$45.4 millionJun 2025 NT$46.3 million25/06Jul 2025 NT$44.1 millionAug 2025 NT$45.3 millionSep 2025 NT$44.8 millionOct 2025 NT$51.5 million25/10Nov 2025 NT$48.3 millionDec 2025 NT$50.8 millionJan 2026 NT$58.4 millionFeb 2026 NT$37.9 million26/02Mar 2026 NT$50.4 millionApr 2026 NT$46.8 millionMay 2026 NT$52.5 millionJun 2026 NT$47.3 million26/06Jul 2026 NT$54.5 millionAug 2026 NT$45.8 millionSep 2026 NT$49 millionOct 2026 NT$50.1 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$50.1 million-2.7%+2.2%
Sep 2026NT$49 million+9.2%+6.9%
Aug 2026NT$45.8 million+1.1%-15.9%
Jul 2026NT$54.5 million+23.6%+15.3%
Jun 2026NT$47.3 million+2.2%-10.0%
May 2026NT$52.5 million+15.7%+12.2%
Apr 2026NT$46.8 million+0.5%-7.2%
Mar 2026NT$50.4 million+6.7%+33.1%
Feb 2026NT$37.9 million-6.6%-35.1%
Jan 2026NT$58.4 million-1.2%+15.0%
Dec 2025NT$50.8 million+7.6%+5.0%
Nov 2025NT$48.3 million-4.8%-6.1%
Oct 2025NT$51.5 million+3.2%+14.8%
Sep 2025NT$44.8 million-1.7%-1.1%
Aug 2025NT$45.3 million-23.1%+2.8%
Jul 2025NT$44.1 million-3.0%-4.7%
Jun 2025NT$46.3 million-12.4%+1.9%
May 2025NT$45.4 million-8.5%-2.5%
Apr 2025NT$46.5 million-3.0%-1.4%
Mar 2025NT$47.2 million-8.1%+16.5%
Feb 2025NT$40.5 million+1.2%-31.4%
Jan 2025NT$59.1 million-17.7%+25.2%
Dec 2024NT$47.2 million-6.6%-7.1%
Nov 2024NT$50.8 million-4.3%+1.8%
Oct 2024NT$49.9 million-2.5%+9.3%

Jan–Oct 2026 cumulative: NT$492.4 million (+4.6% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: Johnson Chemical Pharmaceutical Works vs PEC / Johnson Chemical Pharmaceutical Works vs Lotus Pharm / Johnson Chemical Pharmaceutical Works vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16